Cyclooxygenase 2-Derived Prostaglandin E2 Production by Corticotropin-Releasing Hormone Contributes to the Activated cAMP Response Element Binding Protein Content in Rheumatoid Arthritis Synovial Tissue

Arthritis and Rheumatism

Volumn 50, Issue 4, 2004, Pages 1132-1145

  McEvoy, Alice N ^a   Bresnihan, Barry ^b   FitzGerald, Oliver ^b   Murphy, Evelyn P ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SYNOVIUM; UPREGULATION; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTORS; ARTHRITIS, RHEUMATOID; BLOOD PROTEINS; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; ISOENZYMES; MEMBRANE PROTEINS; PHOSPHORYLATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 1842733190     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20157     Document Type: Article

References (53)

1. Tak PP, Bresnihan B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum 2000;43:2619-33.
2. Koch AE. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 1998;41:951-62.
3. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
4. Wakisaka S, Suzuki N, Takeba Y, Nagafuchi H, Saito N, Hashimoto H, et al. Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1 for synovial cell outgrowth in patients with rheumatoid arthritis. Ann Rheum Dis 1998;57:487-94.
5. Firestein GS, Manning AM. Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum 1999;42:609-21.
6. Miagkov AV, Kovalenko D, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, et al. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A 1998;95:13859-64.
7. Takeba Y, Suzuki N, Wakisaka S, Takeno M, Kaneko A, Asai T, et al. Involvement of cAMP responsive element binding protein (CREB) in the synovial cell hyperfunction in patients with rheumatoid arthritis. Clin Exp Rheumatol 2000;18:47-55.
8. Thomas B, Berenbaum F, Humbert L, Bian H, Bereziat G, Crofford L, et al. Critical role of C/EBPδ and C/EBPβ factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1β in articular chondrocytes. Eur J Biochem 2000;267:6798-809.
9. Siegle I, Klein T, Backman JT, Saal JG, Nusing RM, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 1998;41:122-9.
10. Vane JR, Botting R. Mechanism of action of anti-inflammatory drugs. Adv Exp Med Biol 1997;433:131-8.
11. Robinson DR, Tashjian AH Jr, Levine L. Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 1975;56:1181-8.
12. Mehindate K, al-Daccak R, Dayer JM, Kennedy BP, Kris C, Borgeat P, et al. Superantigen-induced collagenase gene expression in human IFNγ-treated fibroblast-like synoviocytes involves prostaglandin E2. Evidence for a role of cyclooxygenase-2 and cytosolic phospholipase A2. J Immunol 1995;155:3570-7.
13. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-7.
14. Goetzl EJ, An S, Zeng L. Specific suppression by prostaglandin E2 of activation-induced apoptosis of human CD4+CD8+ T lymphoblasts. J Immunol 1995;154:1041-7.
15. Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, et al. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 1996;184:883-91.
16. McCoy JM, Wicks J, Audoly LP. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 2002;110:651-8.
17. Karalis KP, Kontopoulos E, Muglia LJ, Majzoub JA. Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine [published erratum appears in Proc Natl Acad Sci U S A 2000;97:3782]. Proc Natl Acad Sci U S A 1999;96:7093-7.
18. Karalis KP, Kontopoulos E, Muglia LJ, Majzoub JA. Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine [published erratum appears in Proc Natl Acad Sci U S A 2000;97:3782]. Proc Natl Acad Sci U S A 1999;96:7093-7.
19. Fife MS, Fisher SA, John S, Worthington J, Shah CJ, Ollier WE, et al. Multipoint linkage analysis of a candidate gene locus in rheumatoid arthritis demonstrates significant evidence of linkage and association with the corticotropin-releasing hormone genomic region. Arthritis Rheum 2000;43:1673-8.
20. Crofford LJ, Sano H, Karalis K, Friedman TC, Epps HR, Remmers EF, et al. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J Immunol 1993;151:1587-96.
21. Murphy EP, McEvoy A, Conneely OM, Bresnihan B, FitzGerald O. Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis. Arthritis Rheum 2001;44:782-93.
22. McEvoy AN, Bresnihan B, FitzGerald O, Murphy EP. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1α corticotropin-releasing hormone receptor. Arthritis Rheum 2001;44:1761-7.
23. McEvoy A, Bresnihan B, FitzGerald O, Murphy EP. Corticotropin-releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathway. Ann N Y Acad Sci 2002;966:119-30.
24. Webster E, Barrientos RM, Contoreggi C, Isaac MG, Ligier S, Gabry KE, et al. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J Rheumatol 2002;29:1252-61.
25. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
26. Haas C, Aicher WK, Dinkel A, Peter HH, Eibel H. Characterisation of SV40 T antigen immortalized human synovial fibroblasts: maintained expression patterns of EGR-1, HLA-DR, and some surface receptors. Rheumatol Int 1997;16:241-7.
27. Murphy EP, Conneely OM. Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the NURR1/NUR77 subfamily of nuclear receptors. Mol Endocrinol 1997;11:39-47.
28. Rainnie DG, Fernhout BJ, Shinnick-Gallagher P. Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro. J Pharmacol Exp Ther 1992;263:846-58.
29. Fleisher-Berkovich S, Rimon G, Danon A. Modulation of endothelial prostaglandin synthesis by corticotropin releasing factor and antagonists. Eur J Pharmacol 1998;353:297-302.
30. Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello A. Human recombinant interleukin-1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986;77:645-8.
31. O'Neill LA, Barrett M, Lewis GP. Induction of cyclo-oxygenase by interleukin-1 in rheumatoid synovial cells. FEBS Lett 1987;212:35-9.
32. Crofford LJ, Wilder R, Ristimaki AP, Sano H. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissue. J Clin Invest 1994;93:1095-101.
33. Faour WH, He Y, He QW, de Ladurantaye M, Quintero M, Mancini A, et al. Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1β-treated human synovial fibroblasts. J Biol Chem 2001;276:31720-31.
34. Crofford LJ, Tan B, McCarthy CJ, Hla T. Involvement of nuclear factor κB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum 1997;40:226-36.
35. Blanco FJ, Guitian R, Moreno J, de Toro FJ, Galdo F. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J Rheumatol 1999;26:1366-73.
36. Moses VS, Hardy J, Bertone AL, Weisbrode SE. Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants. Am J Vet Res 2001;62:54-60.
37. Castor C. Connective tissue activation. VII. Evidence supporting a role for prostaglandins and cyclic nucleotides. J Lab Clin Med 1975;85:392-404.
38. Rossant CJ, Pinnock RD, Hughes J, Hall MD, McNulty S. Corticotropin-releasing factor type-I and type-2a receptors regulate phosphorylation of calcium/cyclic adenosine 3′, 5′-monophosphate response element-binding protein and activation of p42/44 mitogen-activated protein kinase. Endocrinology 1999;140:1525-36.
39. De Cesare D, Fimia G, Sassone-Corsi P. Signaling routes to CREM and CREB: plasticity in transcriptional activation. Trends Biochem Sci 1999;24:281-5.
40. Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11.
41. McEvoy A, Murphy EA, Ponnio T, Conneely OM, Bresnihan B, Fitzgerald O, et al. Activation of nuclear orphan receptor NURR1 transcription by NF-κB and cyclic adenosine 5′-monophosphate response element binding protein in rheumatoid arthritis synovial tissue. J Immunol 2002;168:2979-87.
42. Dayer JM, Burger D. Cytokines and direct cell contact in synovitis: relevance to therapeutic intervention. Arthritis Res 1999;1:17-20.
43. Tetlow LC, Harper N, Dunningham T, Morris MA, Bertfield H, Woolley DE. Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro. Ann Rheum Dis 1998;57:25-32.
44. Woods JM, Tokuhira M, Berry JC, Katschke KJ Jr, Kurata H, Damergis JA Jr, et al. Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo. J Investig Med 1999;47:285-92.
45. Agelaki S, Tsatsanis C, Gravanis A, Margioris AN. Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun 2002;70:6068-74.
46. 2. Arthritis Rheum 1994;37:653-61.
47. Gibbs DM, Vale W. Presence of corticotropin releasing factor-like immunoreactivity in hypophysial portal blood. Endocrinology 1982;111:1418-20.
48. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991;254:421-3.
49. Choy E, Panayi G. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.
50. Geng Y, Blanco F, Cornelisson M, Lotz M. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol 1995;155:796-801.
51. Lasa M, Mahtani K, Finch A, Brewer G, Saklatvala J, Clark AR. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 2000;20:4265-74.
52. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J 1996;15:4629-42.
53. Schroer K, Zhu Y, Saunders MA, Deng WG, Xu XM, Meyer-Kirchrath J, et al. Obligatory role of cyclic adenosine monophosphate response element in cyclooxygenase-2 promoter induction and feedback regulation by inflammatory mediators. Circulation 2002;105:2760-5.